Möchten Sie immer auf dem neuesten Stand bleiben?

SHENZHEN, CHINA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a...

New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a...

Media ReleaseCOPENHAGEN, Denmark; December 8, 2025 Two-year epcoritamab monotherapy data demonstrate high complete response and encouraging survival rates in patients with Richter transformation...

VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) --  USANewsGroup.com News Commentary – Hospitals running on thin margins are done chasing clinical moonshots[1]. They want AI that...

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Singapore Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose,...

Patients in 200 mg BID cohort had median progression free survival of 6.2 months and median overall survival of 28.1 months, comparing favorably to results with other therapies Data supports ongoing...

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. The global In Vitro Diagnostics (IVD) market is...

This white paper exposes how the World Health Organization's FCTC has been captured by NGOs undermining the treaty's credibility.

Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab and lenalidomide (EPKINLY+ R2) resulted in statistically significant and...